Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | -2.88% | +12.22% | -5.61% |
05-14 | Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | MiNK Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.05M 2.76B |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.5B | Net income 2025 * | -36M -2.83B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.53
x | P/E ratio 2025 * |
-1.52
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 25.38% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | -2.88% | ||
1 week | +12.22% | ||
Current month | +2.02% | ||
1 month | +15.87% | ||
3 months | +9.90% | ||
6 months | -1.94% | ||
Current year | -5.61% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 31/01/21 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 29/02/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 30/06/17 |
Director/Board Member | 66 | 30/06/17 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 31/08/21 |
Date | Price | Change | Volume |
---|---|---|---|
17/05/24 | 1.01 | -2.88% | 68,768 |
16/05/24 | 1.04 | 0.00% | 76,614 |
15/05/24 | 1.04 | -7.14% | 560,216 |
14/05/24 | 1.12 | +14.31% | 633,700 |
13/05/24 | 0.9798 | +8.87% | 4,583,316 |
Delayed Quote Nasdaq, May 17, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.61% | 35.05M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- INKT Stock